<DOC>
	<DOCNO>NCT00099957</DOCNO>
	<brief_summary>This study conduct United States . Many people type 2 diabetes also high cholesterol level . The purpose study evaluate effect vildagliptin , unapproved drug , blood lipid measure triglycerides cholesterol people type 2 diabetes .</brief_summary>
	<brief_title>A Clinical Study Assess Effect Vildagliptin Postprandial Lipid Parameters Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<criteria>Blood glucose criterion must meet Genetic marker associate increase risk cardiovascular disease Not currently drug therapy type 2 diabetes Body mass index ( BMI ) range 2540 Pregnancy lactation Type 1 diabetes High cholesterol define protocol Evidence serious diabetic complication Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>vildagliptin</keyword>
</DOC>